212 related articles for article (PubMed ID: 37110374)
1. Gut Bacterial Communities in HIV-Infected Individuals with Metabolic Syndrome: Effects of the Therapy with Integrase Strand Transfer Inhibitor-Based and Protease Inhibitor-Based Regimens.
Baltazar-Díaz TA; Amador-Lara F; Andrade-Villanueva JF; González-Hernández LA; Cabrera-Silva RI; Sánchez-Reyes K; Álvarez-Zavala M; Valenzuela-Ramírez A; Del Toro-Arreola S; Bueno-Topete MR
Microorganisms; 2023 Apr; 11(4):. PubMed ID: 37110374
[TBL] [Abstract][Full Text] [Related]
2. A Two-Faced Gut Microbiome: Butyrogenic and Proinflammatory Bacteria Predominate in the Intestinal Milieu of People Living with HIV from Western Mexico.
Baltazar-Díaz TA; Andrade-Villanueva JF; Sánchez-Álvarez P; Amador-Lara F; Holguín-Aguirre T; Sánchez-Reyes K; Álvarez-Zavala M; López-Roa RI; Bueno-Topete MR; González-Hernández LA
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732048
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota from Mexican patients with metabolic syndrome and HIV infection: An inflammatory profile.
Amador-Lara F; Andrade-Villanueva JF; Vega-Magaña N; Peña-Rodríguez M; Alvarez-Zavala M; Sanchez-Reyes K; Toscano-Piña M; Peregrina-Lucano AA; Del Toro-Arreola S; González-Hernández LA; Bueno-Topete MR
J Appl Microbiol; 2022 May; 132(5):3839-3852. PubMed ID: 35218591
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients.
Villanueva-Millán MJ; Pérez-Matute P; Recio-Fernández E; Lezana Rosales JM; Oteo JA
J Int AIDS Soc; 2017 Mar; 20(1):21526. PubMed ID: 28362071
[TBL] [Abstract][Full Text] [Related]
5. Integrase Inhibitors Partially Restore Bacterial Translocation, Inflammation and Gut Permeability Induced by HIV Infection: Impact on Gut Microbiota.
Villoslada-Blanco P; Pérez-Matute P; Íñiguez M; Recio-Fernández E; Blanco-Navarrete P; Metola L; Ibarra V; Alba J; de Toro M; Oteo JA
Infect Dis Ther; 2022 Aug; 11(4):1541-1557. PubMed ID: 35618952
[TBL] [Abstract][Full Text] [Related]
6. Impact of long-term antiretroviral therapy on gut and oral microbiotas in HIV-1-infected patients.
Imahashi M; Ode H; Kobayashi A; Nemoto M; Matsuda M; Hashiba C; Hamano A; Nakata Y; Mori M; Seko K; Nakahata M; Kogure A; Tanaka Y; Sugiura W; Yokomaku Y; Iwatani Y
Sci Rep; 2021 Jan; 11(1):960. PubMed ID: 33441754
[TBL] [Abstract][Full Text] [Related]
7. Reduction of CD8 T Cell Functionality but Not Inhibitory Capacity by Integrase Inhibitors.
Richter E; Bornemann L; Korencak M; Alter G; Schuster M; Esser S; Boesecke C; Rockstroh J; Gunzer M; Streeck H
J Virol; 2022 Mar; 96(5):e0173021. PubMed ID: 35019724
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.
Zhou Y; Ou Z; Tang X; Zhou Y; Xu H; Wang X; Li K; He J; Du Y; Wang H; Chen Y; Nie Y
J Cell Mol Med; 2018 Apr; 22(4):2263-2271. PubMed ID: 29411528
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral Therapy Anchor-based Trends in Body Mass Index Following Treatment Initiation Among Military Personnel with HIV.
Kline MDA; Daniels C; Xu X; Sunil T; Ganesan A; Agan BK; Colombo RE; Kronmann KC; Blaylock JM; Okulicz JF; Markelz AE
Mil Med; 2021 Feb; 186(3-4):279-285. PubMed ID: 33128552
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018-2020).
Yang Z; Yang X; Deng X; Wei S; Liu J; Ma J; Zhao Q; Huo Y
Infection; 2021 Dec; 49(6):1195-1202. PubMed ID: 34279816
[TBL] [Abstract][Full Text] [Related]
11. Real-World Assessment of Weight Change in African American Females and Hispanics with HIV-1 After Initiating Integrase Strand-Transfer Inhibitors or Protease Inhibitors.
Chen YW; Anderson D; Pericone CD; Donga P
J Health Econ Outcomes Res; 2022; 9(1):1-10. PubMed ID: 35083364
[No Abstract] [Full Text] [Related]
12. Switching regimens in virologically suppressed HIV-1-infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimens.
Raffi F; Esser S; Nunnari G; Pérez-Valero I; Waters L
HIV Med; 2016 Oct; 17 Suppl 5():3-16. PubMed ID: 27714978
[TBL] [Abstract][Full Text] [Related]
13. Real-World Assessment of Weight Change in People with HIV-1 After Initiating Integrase Strand Transfer Inhibitors or Protease Inhibitors.
Chen YW; Hardy H; Pericone CD; Chow W
J Health Econ Outcomes Res; 2020; 7(2):102-110. PubMed ID: 32766375
[TBL] [Abstract][Full Text] [Related]
14. Comparison of weight gain after antiretroviral switch to integrase strand transfer inhibitor or tenofovir alafenamide-based therapy.
Sjaarda A; Bernstein A; Sparks A; Saber S; Siegel M
Infection; 2022 Apr; 50(2):407-412. PubMed ID: 34449049
[TBL] [Abstract][Full Text] [Related]
15. Impact of HIV infection and integrase strand transfer inhibitors-based treatment on the gut virome.
Villoslada-Blanco P; Pérez-Matute P; Íñiguez M; Recio-Fernández E; Jansen D; De Coninck L; Close L; Blanco-Navarrete P; Metola L; Ibarra V; Alba J; Matthijnssens J; Oteo JA
Sci Rep; 2022 Dec; 12(1):21658. PubMed ID: 36522388
[TBL] [Abstract][Full Text] [Related]
16. Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy.
Russo E; Nannini G; Sterrantino G; Kiros ST; Di Pilato V; Coppi M; Baldi S; Niccolai E; Ricci F; Ramazzotti M; Pallecchi M; Lagi F; Rossolini GM; Bartoloni A; Bartolucci G; Amedei A
World J Gastroenterol; 2022 Feb; 28(6):635-652. PubMed ID: 35317423
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of HIV-1 Integrase Strand Transfer Inhibitor Resistance in Treatment-Naïve Voluntary Counselling and Testing Clients by Population Sequencing and Illumina Next-Generation Sequencing in Taiwan.
Tsai HC; Chen IT; Tsai KW; Lee SS; Chen YS
Infect Drug Resist; 2020; 13():4519-4529. PubMed ID: 33364799
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with HIV-1 resistance to integrase strand transfer inhibitors in Spain: Implications for dolutegravir-containing regimens.
Gil H; Delgado E; Benito S; Moreno-Lorenzo M; Thomson MM;
Front Microbiol; 2022; 13():1051096. PubMed ID: 36578581
[TBL] [Abstract][Full Text] [Related]
19. Beyond the effects of HIV infection and integrase inhibitors-based therapies on oral bacteriome.
Villoslada-Blanco P; Pérez-Matute P; Recio-Fernández E; Íñiguez M; Blanco-Navarrete P; Metola L; Ibarra V; Alba J; de Toro M; Oteo JA
Sci Rep; 2023 Aug; 13(1):14327. PubMed ID: 37653055
[TBL] [Abstract][Full Text] [Related]
20. The Gut Microbiota of Healthy Chilean Subjects Reveals a High Abundance of the Phylum Verrucomicrobia.
Fujio-Vejar S; Vasquez Y; Morales P; Magne F; Vera-Wolf P; Ugalde JA; Navarrete P; Gotteland M
Front Microbiol; 2017; 8():1221. PubMed ID: 28713349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
